Systole Remedies in developing new formulations, undertaking bioequivalence studies, clinical trials, obtaining Drug Controller General of India’s (DCGI) approval for franchise and marketing of new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Adina’s own technology to its customers under their brand names. Systole Remedies manufacturer innovative and technology driven products…
